IARC Monographs Volume 100E
Tobacco Smoking

Supplementary Web Tables, Section 2, Cancer in Humans

  These web tables formed part of the original submission and have been peer reviewed. They
  are posted as supplied by the Working Group. Readers are requested to report any errors to:
  edit-vol100E@iarc.fr.
Table 2.1   Cohort studies of cancer and cigarette smoking
Table 2.2   Cohort studies of active smokers and lung cancer
Table 2.3   Meta-analysis and pooled studies of tobacco smoke and lung cancer focused on exposure–response
Table 2.4   Meta-analysis of studies of tobacco smoke and lung cancer focused on sex disparities in susceptibility
Table 2.5   Cohort Studies of tobacco smoke and lung cancer focused on sex disparities in susceptibility
Table 2.6   Meta-analysis/pooled studies of  tobacco smoke and lung cancer focused on ethnic/racial disparities in susceptibility
Table 2.7   Cohort studies on tobacco smoking and cancer of the oral cavity
Table 2.8   Case-control studies on tobacco smoking and oral cancer: main characteristics of study design
Table 2.9   Case-control studies on tobacco smoking and oral cancer: intensity, duration and age at starting smoking
Table 2.10 Case-control studies on tobacco smoking and oral cancer: smoking cessation
Table 2.11 Case-control studies on tobacco smoking and oral cancer: type of tobacco or cigarette
Table 2.12   Cohort studies on tobacco smoking and pharyngeal cancer
Table 2.13   Case-control studies on tobacco smoking and pharyngeal cancer: main characteristics of study design
Table 2.14   Case-control studies on tobacco smoking and pharyngeal cancer
Table 2.15   Cohort studies on tobacco smoking and nasal cavity and sinuses cancer
Table 2.16   Cohort studies on tobacco smoking and nasopharynx cancer
Table 2.17   Case-control studies on tobacco smoking and nasopharyngeal cancer: main characteristics of study design
Table 2.18   Case-control studies on tobacco smoking and nasopharyngeal cancer
Table 2.19   Cohort studies on tobacco smoking and oesophageal cancer
Table 2.20   Case-control studies on tobacco smoking and oesophageal cancer (unspecified) or squamous-cell carcinoma of the oesophagus: main characteristics of study design
Table 2.21  Case-control studies on tobacco smoking and oesophageal cancer (unspecified) or squamous cell carcinoma of the oesophagus
Table 2.22   Case-control studies on tobacco smoking and oesophageal cancer (unspecified) or squamous cell carcinoma of the oesophagus: smoking cessation
Table 2.23   Case-control studies on tobacco smoking and oesophageal cancer (unspecified) or squamous cell carcinoma of the oesophagus: type of tobacco and/or cigarette
Table 2.24   Case-control studies on tobacco smoking and adenocarcinoma of the esophagus: main characteristics of study design
Table 2.25   Case-control studies on tobacco smoking and adenocarcinoma of the oesophagus
Table 2.26   Cohort studies on tobacco smoking and laryngeal cancer
Table 2.27   Case-control studies on tobacco smoking and laryngeal cancer: main characteristics of study design
Table 2.28   Case-control studies on tobacco smoking and laryngeal cancer
Table 2.29   Case-control studies on tobacco smoking and laryngeal cancer: smoking cessation
Table 2.30   Case-control studies on tobacco smoking and laryngeal cancer: type of tobacco and/or cigarette
Table 2.31   Cohort studies on tobacco smoking and upper aero-digestive cancer squamous cell carcinoma
Table 2.32   Case-control studies on tobacco smoking and cancers of the upper aerodigestive tract: main characteristics of study design
Table 2.33   Case-control studies on tobacco smoking and cancers of the upper aerodigestive tract combined
Table 2.34   Case-control studies on tobacco smoking and cancers of the upper aerodigestive tract combined: smoking cessation
Table 2.35   Case-control studies on tobacco smoking and cancers of the upper aerodigestive tract: type of tobacco and/or cigarette
Table 2.36 Meta analysis of cigarette smoking and stomach cancer
Table 2.37 Cohort studies on smoking and risk of stomach cancer
Table 2.38   Case-control studies on smoking and risk of stomach cancer
Table 2.39   Meta- and pooled analyses of cigarette smoking and pancreatic cancer
Table 2.40   Case–control studies of second-hand tobacco smoke and cancer of the gastrointestinal tract
Table 2.41   Case-control studies on smoking and risk of pancreatic cancer
Table 2.42   Cohort studies on smoking and risk of colorectal cancer
Table 2.43   Smoking status and cancer incidence/mortality
Table 2.44   Case-control studies on smoking and colorectal cancer
Table 2.45   Case-control studies on smoking and risk of colorectal adenoma
Table 2.46   Case–control and cohort studies of Hepatocellular carcinoma – studies after year 2000
Table 2.47  Case–control studies of kidney cancer
Table 2.48   Case–control studies of urinary tract cancer
Table 2.49   Cohort studies of urinary tract cancer
Table 2.50   Case–control studies of leukemias and lymphomas
Table 2.51   Cohort studies of leukemias and lymphomas
Table 2.52   Recent cohort studies of active smoking and breast cancer incidence by smoking status
Table 2.53  Recent case-control studies of active smoking and breast cancer incidence by smoking status
Table 2.54   Cohort studies of breast cancer risk by years since cessation of active smoking
Table 2.55   Case-control studies of breast cancer risk by years since cessation of active smoking
Table 2.56   Cohort studies of active smoking and risk of breast cancer: duration of smoking
Table 2.57 Case–control studies of active smoking and risk of breast cancer: duration of smoking
Table 2.58 Cohort studies of active smoking and risk of breast cancer: age at initiation
Table 2.59   Case–control studies of active smoking and risk of breast cancer: age at initiation
Table 2.60   Cohort studies of active smoking and risk of breast cancer: smoking initiation relative to first birth
Table 2.61   Case–control studies of active smoking and risk of breast cancer: smoking initiation relative to first birth
Table 2.62   Recent case–control studies that examined smoking and breast cancer by menopausal status
Table 2.63   Studies of smoking and breast cancer risk by genetic subtype
Table 2.64   Case–control studies on tobacco smoking and cervical cancer: main characteristics of study design
Table 2.65   Case–control studies on tobacco smoking and invasive cervical cancer
Table 2.66   Cohort studies on tobacco smoking and invasive cervical cancer
Table 2.67   Pooled Analyses on tobacco smoking and cervical cancer
Table 2.68  Additional cohort studies on tobacco smoking and cervical cancer, cervical intraepithelial neoplasia and carcinoma in situ (with or without control for human papilloma virus status)
Table 2.69   Pooled analyses on tobacco smoking and cervical cancer, cervical intraepithelial neoplasia and carcinoma in situ (with or without control for human papilloma virus status)
Table 2.70   Case–control studies on smoking and endometrial cancer: main characteristics of study design
Table 2.71   Case–control studies on smoking and endometrial cancer
Table 2.72   Description of additional cohort studies on smoking and cancer of the endometrium
Table 2.73   Cohort studies on smoking and endometrial cancer
Table 2.74   Description of additional cohort studies on smoking and prostate cancer
Table 2.75   Cohort studies on smoking and prostate cancer
Table 2.76   Case–control studies on smoking and ovarian cancer: main characteristics of study design
Table 2.77   Case–control studies on smoking and ovarian cancer
Table 2.78  Description of cohort studies on smoking and ovarian cancer
Table 2.79  Cohort studies on smoking and ovarian cancer
Table 2.80   Epidemiological studies on smoking and cancer of the thyroid: main characteristics of study design
Table 2.81   Case–control studies on smoking and cancer of the thyroid
Table 2.82   Description of additional cohort studies on smoking and cancer of the thyroid
Table 2.83   Cohort studies on smoking and cancer of the thyroid
Table 2.84   Case–control studies on smoking and penile cancer: main characteristics of study design
Table 2.85   Case–control studies on smoking and penile cancer
Table 2.86   Review studies and other studies on smoking and penile cancer: main characteristics of study
Table 2.87   Other studies on smoking and penile cancer
Table 2.88   Case–control studies of Bidi smoking and cancer
Table 2.89  Description of case–control studies of the interaction of smoking and alcohol in the causation of cancer at various sites
Table 2.90   Description of cohort studies of the interaction of smoking and alcohol in the causation of cancer at various sites
Table 2.91   Studies with information on interaction of smoking and alcohol in the causation of cancer at various sites (UADT new studies screened from 1999 until now)